mRNA vaccine Current Affairs, GK & News

Clinical Trials of mRNA HIV Vaccine

Phase 1 clinical trials for the evaluation of three HIV vaccines have been launched by the National Institute of Allergy and Infectious Diseases (NIAID), United States. Overview: These vaccines are based on a messenger RNA (mRNA) platform. This is a technology that is used in several COVID-19 vaccines. The study is being sponsored by NIAID ..

Month: 

Category: 

Topics: 

Conditional market approval for Covaxin, Covishield

The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the vaccines will not be available in retail medical stores. What is conditional market authorisation? The Serum Institute vaccine COVISHELD and Bharat Biotech’s COVAXIN were administered in the ..

Month: 

Category: 

Topics: 

Precautionary vaccine jabs in India

The Government of India is to provide third dose of vaccine. This third dose has been named “precaution dose” or booster dose. About the precaution dose The health care workers, comorbid patients (people with severe medical conditions) and frontline workers are eligible to get the precaution dose. Five states in the country are to go ..

Month: 

Category: 

Topics: 

India’s first mRNA-based COVID-19 vaccine

The Drugs Controller General of India (DGCI) gave nod for Phase-2 and Phase-3 trails of India’s first mRNA-based COVID-19 vaccine. Highlights First mRNA-based covid-19 vaccine, called HGCO19, is being developed by a Pune-based biotechnology company, Genova Biopharmaceuticals Ltd. The company submitted its interim clinical data for Phase I study to the Central Drugs Standard Control ..

Month: 

Category: 

Topics: